Yanfen Hu

2.3k total citations
67 papers, 1.3k citations indexed

About

Yanfen Hu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Yanfen Hu has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Genetics and 19 papers in Oncology. Recurrent topics in Yanfen Hu's work include BRCA gene mutations in cancer (19 papers), DNA Repair Mechanisms (14 papers) and Estrogen and related hormone effects (11 papers). Yanfen Hu is often cited by papers focused on BRCA gene mutations in cancer (19 papers), DNA Repair Mechanisms (14 papers) and Estrogen and related hormone effects (11 papers). Yanfen Hu collaborates with scholars based in United States, China and France. Yanfen Hu's co-authors include Sagar Ghosh, Yunzhe Lu, Rong Li, Rong Li, Rong Li, Tyler J. Curiel, Huai-Chin Chiang, Adam J. Katz, Qinong Ye and Tsuyoshi Miyake and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Yanfen Hu

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfen Hu United States 22 818 350 334 187 162 67 1.3k
Valerie C. L. Lin Singapore 21 505 0.6× 304 0.9× 431 1.3× 209 1.1× 135 0.8× 52 1.1k
Suraj Menon United Kingdom 15 969 1.2× 337 1.0× 279 0.8× 191 1.0× 278 1.7× 30 1.5k
Bruno Moncharmont Italy 23 933 1.1× 264 0.8× 624 1.9× 149 0.8× 171 1.1× 46 1.5k
Hany Abdel-Hafiz United States 16 435 0.5× 264 0.8× 385 1.2× 306 1.6× 112 0.7× 24 994
Yie Liu United States 31 1.8k 2.1× 441 1.3× 201 0.6× 201 1.1× 218 1.3× 62 2.5k
Wei‐Hsiung Yang United States 19 694 0.8× 237 0.7× 260 0.8× 198 1.1× 348 2.1× 39 1.3k
Ming You United States 16 1.0k 1.3× 339 1.0× 253 0.8× 221 1.2× 470 2.9× 33 1.6k
J. Don Chen United States 15 1.4k 1.7× 245 0.7× 801 2.4× 199 1.1× 109 0.7× 17 1.9k
Paul Kroeger United States 18 1.1k 1.3× 158 0.5× 185 0.6× 242 1.3× 328 2.0× 29 1.5k
Yoshihiko Uehara Japan 15 835 1.0× 187 0.5× 182 0.5× 176 0.9× 135 0.8× 30 1.6k

Countries citing papers authored by Yanfen Hu

Since Specialization
Citations

This map shows the geographic impact of Yanfen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfen Hu more than expected).

Fields of papers citing papers by Yanfen Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfen Hu. The network helps show where Yanfen Hu may publish in the future.

Co-authorship network of co-authors of Yanfen Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfen Hu. A scholar is included among the top collaborators of Yanfen Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfen Hu. Yanfen Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Huai-Chin, et al.. (2024). R-loop functions in Brca1 -associated mammary tumorigenesis. Proceedings of the National Academy of Sciences. 121(33). e2403600121–e2403600121. 4 indexed citations
2.
Sun, Dawei, Haixia Jiang, Quan Qiu, et al.. (2024). Abstract 183: A novel bispecific antibody macrophage engager (BiME) designed for the treatment of solid tumors. Cancer Research. 84(6_Supplement). 183–183. 1 indexed citations
3.
Wu, Hao, Jin Wu, Ming Liu, et al.. (2023). Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. Journal of Translational Medicine. 21(1). 191–191. 57 indexed citations
4.
Wu, Bogang, Huai-Chin Chiang, Haihui Pan, et al.. (2023). BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunity. Journal for ImmunoTherapy of Cancer. 11(2). e005852–e005852. 8 indexed citations
5.
Zhang, Xintong, Hao Wu, Yanfen Hu, et al.. (2023). A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features. Functional & Integrative Genomics. 23(2). 109–109. 11 indexed citations
6.
Wu, Bogang, Xiaowen Zhang, Huai-Chin Chiang, et al.. (2022). RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity. Nature Communications. 13(1). 2155–2155. 9 indexed citations
7.
Yuan, Bin, Curtis A. Clark, Bogang Wu, et al.. (2021). Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch. Journal for ImmunoTherapy of Cancer. 9(1). e001932–e001932. 34 indexed citations
8.
Yang, Jing, et al.. (2021). BRCA1 Antibodies Matter. International Journal of Biological Sciences. 17(12). 3239–3254. 4 indexed citations
9.
Wu, Bogang, Huai-Chin Chiang, Xiujie Sun, et al.. (2020). Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation. Journal for ImmunoTherapy of Cancer. 8(2). e000964–e000964. 16 indexed citations
10.
Cao, Fei, Peng Liu, Xianbin Zhang, et al.. (2019). Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo. Bioscience Reports. 39(1). 3 indexed citations
11.
Wu, Bogang, Xiujie Sun, Harshita B. Gupta, et al.. (2018). Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer. OncoImmunology. 7(11). e1500107–e1500107. 76 indexed citations
12.
Xie, Xianhe, Yanfen Hu, Chao Jing, et al.. (2017). A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast Cancer. Europe PMC (PubMed Central). 18(3). 727–733. 1 indexed citations
13.
Chiang, Huai-Chin, et al.. (2015). Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Wang, Xiaochuang, Lingxia Li, Xiaolin Niu, et al.. (2014). mTOR Enhances Foam Cell Formation by Suppressing the Autophagy Pathway. DNA and Cell Biology. 33(4). 198–204. 48 indexed citations
15.
Yi, Huashan, Juan Song, Yanfen Hu, et al.. (2014). BmICE-2 is a novel pro-apoptotic caspase involved in apoptosis in the silkworm, Bombyx mori. Biochemical and Biophysical Research Communications. 445(1). 100–106. 14 indexed citations
16.
Lu, Yunzhe, Jiezhi Li, Dongmei Cheng, et al.. (2012). The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation. Journal of Biological Chemistry. 287(49). 41014–41022. 50 indexed citations
17.
Chiang, Huai-Chin, Sreejith J. Nair, I‐Tien Yeh, et al.. (2012). Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier. Experimental Hematology and Oncology. 1(1). 31–31. 8 indexed citations
18.
Hu, Yanfen. (2011). Effect of Periplaneta americana extract on two human lung tumor cell lines. Yaowu fenxi zazhi. 4 indexed citations
19.
Ghosh, Sagar, et al.. (2009). IKKβ Mediates Cell Shape-Induced Aromatase Expression and Estrogen Biosynthesis in Adipose Stromal Cells. Molecular Endocrinology. 23(5). 662–670. 20 indexed citations
20.
Wu, Yimin, Yunzhe Lu, Yanfen Hu, & Rong Li. (2005). Cyclic AMP‐dependent modification of gonad‐selective TAFII105 in a human ovarian granulosa cell line. Journal of Cellular Biochemistry. 96(4). 751–759. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026